1-19 of 19
Aurelien Marabelle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metabolic Tumor Volume Assessed by 18F FDG–PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates

Filippo G. Dall’Olio, Wael Zrafi, Veronique Roelants, Valentina Ambrosini, Aloyse Fourquet, Cristina Mitea, Francesco Passiglia, Matteo Bauckneht, Gerald Bonardel, Nicole Conci, Jose Carlos Benitez, Vincenzo Arena, Céline Namour, Marie Naigeon, Isabelle Monnet, Kristi Beshiri, Delphine Hoton, Safiye Dursun, François Xavier Danlos, Giulia Argalia, Mihaela Aldea, Guido Rovera, Lisa Derosa, Valerio Iebba, Hester A. Gietema, Valerie Gounant, Valérie Lacroix, Jordi Remon, Daniel Gautheret, Nathalie Chaput, Bastien Job, Patricia L. Kannouche, Monica Velasco-Nuño, Laurence Zitvogel, Eugenia Cella, José Reinaldo Chícharo de Freitas, Damien Vasseur, Mohamed Aymen Bettaieb, Marco Tagliamento, Lizza Hendriks, Antoine Italiano, David Planchard, Aurelien Marabelle, Fabrice Barlesi, Silvia Novello, Desiree De Andreis, Frank Aboubakar Nana, Andrea Ardizzoni, Gerard Zalcman, Camilo Garcia, Benjamin Besse
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2): 352–364.
https://doi.org/10.1158/1078-0432.CCR-24-1993
Published: 17 January 2025
View article titled, Metabolic Tumor Volume Assessed by 18F FDG–PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates
Open the PDF for Metabolic Tumor Volume Assessed by 18F FDG–PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates in another window
Includes: Supplementary data
Journal Articles

Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Younes Belkouchi, Hugues Talbot, Nathalie Lassau, Littisha Lawrance, Siham Farhane, Rahma Feki-Mkaouar, Joya Hadchiti, Lama Dawi, Julien Vibert, Paul-Henry Cournède, Clara Cousteix, Camille Mazza, Michele Kind, Antoine Italiano, Aurelien Marabelle, Samy Ammari, Stephane Champiat
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (8): 1528–1534.
https://doi.org/10.1158/1078-0432.CCR-22-0890
Published: 14 April 2023
View article titled, Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy
Open the PDF for Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Jonathan W. Goldman, Sarina A. Piha-Paul, Brendan Curti, Katrina S. Pedersen, Todd M. Bauer, Stefanie L. Groenland, Richard D. Carvajal, Vaishali Chhaya, Gray Kirby, Kelly McGlinchey, Scott A. Hammond, Katie Streicher, Danielle M. Townsley, Young Kwang Chae, Jens Voortman, Aurelien Marabelle, John Powderly
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17): 3709–3719.
https://doi.org/10.1158/1078-0432.CCR-21-3016
Published: 01 September 2022
View article titled, Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors
Open the PDF for Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Interventional Radiology for Local Immunotherapy in Oncology

Lambros Tselikas, Stephane Champiat, Rahul A. Sheth, Steve Yevich, Samy Ammari, Frederic Deschamps, Siham Farhane, Charles Roux, Sandrine Susini, Severine Mouraud, Alexandre Delpla, Thibault Raoult, Caroline Robert, Christophe Massard, Fabrice Barlesi, Jean-Charles Soria, Aurélien Marabelle, Thierry de Baere
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (10): 2698–2705.
https://doi.org/10.1158/1078-0432.CCR-19-4073
Published: 15 May 2021
View article titled, Interventional Radiology for Local Immunotherapy in Oncology
Open the PDF for Interventional Radiology for Local Immunotherapy in Oncology in another window
Includes: Multimedia, Supplementary data
Journal Articles

Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors

James Spicer, Aurélien Marabelle, Jean-Francois Baurain, Nina Louise Jebsen, Dag Erik Jøssang, Ahmad Awada, Rebecca Kristeleit, Delphine Loirat, George Lazaridis, Christiane Jungels, Paal Brunsvig, Berit Nicolaisen, Andrew Saunders, Hamina Patel, Jérôme Galon, Fabienne Hermitte, Ketil André Camilio, Brynjar Mauseth, Vibeke Sundvold, Baldur Sveinbjørnsson, Øystein Rekdal
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (10): 2755–2763.
https://doi.org/10.1158/1078-0432.CCR-20-3435
Published: 15 May 2021
View article titled, Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
Open the PDF for Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Intratumoral Immunotherapy: From Trial Design to Clinical Practice

Stéphane Champiat, Lambros Tselikas, Siham Farhane, Thibault Raoult, Matthieu Texier, Emilie Lanoy, Christophe Massard, Caroline Robert, Samy Ammari, Thierry De Baère, Aurélien Marabelle
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3): 665–679.
https://doi.org/10.1158/1078-0432.CCR-20-0473
Published: 01 February 2021
View article titled, Intratumoral Immunotherapy: From Trial Design to Clinical Practice
Open the PDF for Intratumoral Immunotherapy: From Trial Design to Clinical Practice in another window
Journal Articles

Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy

Roberto Ferrara, Marie Naigeon, Edouard Auclin, Boris Duchemann, Lydie Cassard, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Aude Desnoyer, Laura Mezquita, Matthieu Texier, Caroline Caramella, Lizza Hendriks, David Planchard, Jordi Remon, Sabina Sangaletti, Claudia Proto, Marina C. Garassino, Jean-Charles Soria, Aurelien Marabelle, Anne-Laure Voisin, Siham Farhane, Benjamin Besse, Nathalie Chaput
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 492–503.
https://doi.org/10.1158/1078-0432.CCR-20-1420
Published: 19 January 2021
View article titled, Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Open the PDF for Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)

Martin Smoragiewicz, Alex A. Adjei, Emiliano Calvo, Josep Tabernero, Aurélien Marabelle, Christophe Massard, Jun Tang, Elisabeth G.E. de Vries, Jean-Yves Douillard, Lesley Seymour
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2461–2465.
https://doi.org/10.1158/1078-0432.CCR-19-3136
Published: 01 June 2020
View article titled, Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)
Open the PDF for Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT) in another window
Journal Articles

Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection

Mark Aleynick, Judit Svensson-Arvelund, Christopher R. Flowers, Aurélien Marabelle, Joshua D. Brody
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6283–6294.
https://doi.org/10.1158/1078-0432.CCR-18-1800
Published: 01 November 2019
View article titled, Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection
Open the PDF for Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection in another window
Journal Articles

Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Letter

Roberto Ferrara, Sandrine Susini, Aurelien Marabelle
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (11): 3468.
https://doi.org/10.1158/1078-0432.CCR-18-3740
Published: 03 June 2019
View article titled, Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers—Letter
Open the PDF for Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers—Letter in another window
Journal Articles

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

Kyung Hae Jung, Patricia LoRusso, Howard Burris, Michael Gordon, Yung-Jue Bang, Matthew D. Hellmann, Andrés Cervantes, Maria Ochoa de Olza, Aurelien Marabelle, F. Stephen Hodi, Myung-Ju Ahn, Leisha A. Emens, Fabrice Barlesi, Omid Hamid, Emiliano Calvo, David McDermott, Hatem Soliman, Ina Rhee, Ray Lin, Tony Pourmohamad, Julia Suchomel, Amy Tsuhako, Kari Morrissey, Sami Mahrus, Roland Morley, Andrea Pirzkall, S. Lindsey Davis
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (11): 3220–3228.
https://doi.org/10.1158/1078-0432.CCR-18-2740
Published: 03 June 2019
View article titled, Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Open the PDF for Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors in another window
Journal Articles

Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation

Marie-Léa Gauci, Emilie Lanoy, Stéphane Champiat, Caroline Caramella, Samy Ammari, Sandrine Aspeslagh, Andrea Varga, Capucine Baldini, Rastilav Bahleda, Anas Gazzah, Jean-Marie Michot, Sophie Postel-Vinay, Eric Angevin, Vincent Ribrag, Antoine Hollebecque, Jean-Charles Soria, Caroline Robert, Christophe Massard, Aurélien Marabelle
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (3): 946–956.
https://doi.org/10.1158/1078-0432.CCR-18-0793
Published: 01 February 2019
View article titled, Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation
Open the PDF for Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois, Matthias Fischer, James I. Geller, Nicholas G. Gottardo, Aurélien Marabelle, Andrew D.J. Pearson, Shakeel Modak, Thomas Cash, Giles W. Robinson, Marlyane Motta, Alessandro Matano, Suraj G. Bhansali, Jason R. Dobson, Sudha Parasuraman, Susan N. Chi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (10): 2433–2441.
https://doi.org/10.1158/1078-0432.CCR-16-2898
Published: 14 May 2017
View article titled, A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Open the PDF for A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

Stéphane Champiat, Laurent Dercle, Samy Ammari, Christophe Massard, Antoine Hollebecque, Sophie Postel-Vinay, Nathalie Chaput, Alexander Eggermont, Aurélien Marabelle, Jean-Charles Soria, Charles Ferté
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (8): 1920–1928.
https://doi.org/10.1158/1078-0432.CCR-16-1741
Published: 13 April 2017
View article titled, Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Open the PDF for Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 in another window
Includes: Supplementary data
Journal Articles

Mutational Landscape and Sensitivity to Immune Checkpoint Blockers

Roman M. Chabanon, Marion Pedrero, Céline Lefebvre, Aurélien Marabelle, Jean-Charles Soria, Sophie Postel-Vinay
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (17): 4309–4321.
https://doi.org/10.1158/1078-0432.CCR-16-0903
Published: 31 August 2016
View article titled, Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
Open the PDF for Mutational Landscape and Sensitivity to Immune Checkpoint Blockers in another window
Journal Articles

Holbrook Kohrt: In Memoriam (1977–2016)

Roch Houot, Russell Pachynski, Debra K. Czerwinski, Matthew J. Goldstein, Idit Sagiv-Barfi, Joshua Brody, Antonia M. Müller, Aurélien Marabelle
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3695–3696.
https://doi.org/10.1158/1078-0432.CCR-16-1181
Published: 14 July 2016
View article titled, Holbrook Kohrt: In Memoriam (1977–2016)
Open the PDF for Holbrook Kohrt: In Memoriam (1977–2016) in another window
Journal Articles

Immune Checkpoint Modulation for Non–Small Cell Lung Cancer

Jean-Charles Soria, Aurélien Marabelle, Julie R. Brahmer, Scott Gettinger
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2256–2262.
https://doi.org/10.1158/1078-0432.CCR-14-2959
Published: 14 May 2015
View article titled, Immune Checkpoint Modulation for Non–Small Cell Lung Cancer
Open the PDF for Immune Checkpoint Modulation for Non–Small Cell Lung Cancer in another window
Journal Articles

Intratumoral Immunization: A New Paradigm for Cancer Therapy

Aurélien Marabelle, Holbrook Kohrt, Christophe Caux, Ronald Levy
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (7): 1747–1756.
https://doi.org/10.1158/1078-0432.CCR-13-2116
Published: 31 March 2014
View article titled, Intratumoral Immunization: A New Paradigm for Cancer Therapy
Open the PDF for Intratumoral Immunization: A New Paradigm for Cancer Therapy in another window
Journal Articles

Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity

Aurélien Marabelle, Holbrook Kohrt, Ronald Levy
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19): 5261–5263.
https://doi.org/10.1158/1078-0432.CCR-13-1923
Published: 01 October 2013
View article titled, Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity
Open the PDF for Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity in another window
Includes: Supplementary data